1 Min Read
Feb 20 (Reuters) - Ultragenyx Pharmaceutical Inc:
* ULTRAGENYX REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND CORPORATE UPDATE
* Q4 LOSS PER SHARE $1.89 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.